This study is in progress, not accepting new patients
HOPE-B: Trial of AMT-061 in Severe or Moderately Severe Hemophilia B Patients
Summary
- Eligibility
- for males ages 18 years and up (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- UniQure Biopharma B.V.
- ID
- NCT03569891
- Phase
- Phase 3
- Study Type
- Interventional
- Last Updated